Chemed Corp. Aktie
560,00 €
Deine Einschätzung
Chemed Corp. Aktie
Was spricht für und gegen Chemed Corp. in den nächsten Jahren?
Pro
Kontra
Rendite von Chemed Corp. im Vergleich
Wertpapier | Ver.(%) | 1W | 1M | 1J | YTD | 3J | 5J |
---|---|---|---|---|---|---|---|
Chemed Corp. | -0,89 % | -1,75 % | -7,44 % | 12,00 % | 7,69 % | 38,61 % | 100,43 % |
Amn Healthcare Svs | - | -0,95 % | -12,61 % | -33,76 % | -22,39 % | -17,46 % | 23,93 % |
Ensign Group Inc. | -0,91 % | 1,82 % | -1,75 % | - | 8,74 % | - | - |
Select Medical Holdings | -3,15 % | -6,82 % | -6,11 % | -2,38 % | 13,89 % | -18,00 % | 113,80 % |
Kommentare
News
VITAS Completes the Previously Announced Purchase of Assets of Covenant in Florida and Alabama
VITAS Healthcare Corporation, a wholly-owned subsidiary of Chemed Corporation (“Chemed”) (NYSE: CHE) announced the completion of the previously announced purchase of all hospice operations and an
Chemed To Report First-Quarter 2024 Earnings April 24, Related Conference Call To Be Held On April 25
Chemed Corporation (NYSE: CHE) today announced that it will release financial results for the first quarter ended March 31, 2024, on Wednesday, April 24, 2024, following the close of trading on the
VITAS To Buy Hospice Assets of Covenant Care in Florida and Alabama
VITAS Healthcare Corporation, a wholly-owned subsidiary of Chemed Corporation (“Chemed”) (NYSE: CHE), announced it entered into an agreement on March 12, 2024 to acquire all hospice operations and